William M. Facteau
Chairman, President & CEO
William M. Facteau joined Earlens Corporation as Chairman, President & CEO in November of 2013. Previously he acted as the Vice Chairman of ExploraMed Development, LLC and as an Entrepreneur in Residence at New Enterprise Associates (NEA). He also serves on the Board of Directors of ExploraMed Development LLC, NeoTract, Inc., and Autonomic Technologies, Inc. (ATI). Facteau was formerly the Chairman of the Board for Cabochon Aesthetics which was acquired in 2014 by Ulthera as well as an independent board member at CV Ingenuity (CVI), Inc., which was acquired by Covidien in 2013. Previous to this, Mr. Facteau was at Johnson and Johnson (JNJ) from January 2010 through January 2012 as Worldwide President of their ENT Division. Facteau joined JNJ via the $800M acquisition of Acclarent, Inc., where he served as the President, CEO, and a member of the Board of Directors since the company’s formation in 2004.